These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 28973155)

  • 41. Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy.
    Shatsberg Z; Zhang X; Ofek P; Malhotra S; Krivitsky A; Scomparin A; Tiram G; Calderón M; Haag R; Satchi-Fainaro R
    J Control Release; 2016 Oct; 239():159-68. PubMed ID: 27569663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. microRNAs: Potential glioblastoma radiosensitizer by targeting radiation-related molecular pathways.
    Bahreyni-Toossi MT; Dolat E; Khanbabaei H; Zafari N; Azimian H
    Mutat Res; 2019 Nov; 816-818():111679. PubMed ID: 31715522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bioinformatics analysis of miRNA expression profile between primary and recurrent glioblastoma.
    Bo LJ; Wei B; Li ZH; Wang ZF; Gao Z; Miao Z
    Eur Rev Med Pharmacol Sci; 2015 Oct; 19(19):3579-86. PubMed ID: 26502847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
    Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
    OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.
    Yu W; Liang S; Zhang C
    Neuromolecular Med; 2018 Dec; 20(4):452-474. PubMed ID: 30182330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
    Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
    PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular mechanisms of microRNAs in glioblastoma pathogenesis.
    Behrooz AB; Latifi-Navid H; Nezhadi A; Świat M; Los M; Jamalpoor Z; Ghavami S
    Biochim Biophys Acta Mol Cell Res; 2023 Aug; 1870(6):119482. PubMed ID: 37146725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma.
    She X; Yu Z; Cui Y; Lei Q; Wang Z; Xu G; Xiang J; Wu M; Li G
    Oncol Rep; 2014 Sep; 32(3):957-64. PubMed ID: 25017996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation.
    Liu YJ; Ma YC; Zhang WJ; Yang ZZ; Liang DS; Wu ZF; Qi XR
    Oncotarget; 2017 Jun; 8(26):42495-42509. PubMed ID: 28477008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme.
    Qiu S; Huang D; Yin D; Li F; Li X; Kung HF; Peng Y
    Biochim Biophys Acta; 2013 Oct; 1832(10):1697-707. PubMed ID: 23707559
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
    Meng Y; Quan L; Liu A
    Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression.
    Gao YT; Chen XB; Liu HL
    Sci Rep; 2016 Sep; 6():32972. PubMed ID: 27595933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM.
    Stojcheva N; Schechtmann G; Sass S; Roth P; Florea AM; Stefanski A; Stühler K; Wolter M; Müller NS; Theis FJ; Weller M; Reifenberger G; Happold C
    Oncotarget; 2016 Mar; 7(11):12937-50. PubMed ID: 26887050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dysregulated miR-671-5p / CDR1-AS / CDR1 / VSNL1 axis is involved in glioblastoma multiforme.
    Barbagallo D; Condorelli A; Ragusa M; Salito L; Sammito M; Banelli B; Caltabiano R; Barbagallo G; Zappalà A; Battaglia R; Cirnigliaro M; Lanzafame S; Vasquez E; Parenti R; Cicirata F; Di Pietro C; Romani M; Purrello M
    Oncotarget; 2016 Jan; 7(4):4746-59. PubMed ID: 26683098
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-195, miR-455-3p and miR-10a( *) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells.
    Ujifuku K; Mitsutake N; Takakura S; Matsuse M; Saenko V; Suzuki K; Hayashi K; Matsuo T; Kamada K; Nagata I; Yamashita S
    Cancer Lett; 2010 Oct; 296(2):241-8. PubMed ID: 20444541
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas.
    Wu ZB; Cai L; Lin SJ; Lu JL; Yao Y; Zhou LF
    Brain Res; 2013 Sep; 1529():16-25. PubMed ID: 23892108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.
    Haapa-Paananen S; Chen P; Hellström K; Kohonen P; Hautaniemi S; Kallioniemi O; Perälä M
    PLoS One; 2013; 8(4):e60930. PubMed ID: 23577178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
    Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
    Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spatial Dissection of Invasive Front from Tumor Mass Enables Discovery of Novel microRNA Drivers of Glioblastoma Invasion.
    Huang Y; Qi L; Kogiso M; Du Y; Braun FK; Zhang H; Huang LF; Xiao S; Teo WY; Lindsay H; Zhao S; Baxter P; Su JMF; Adesina A; Yang J; Brabetz S; Kool M; Pfister SM; Chintagumpala M; Perlaky L; Wang Z; Zhou Y; Man TK; Li XN
    Adv Sci (Weinh); 2021 Dec; 8(23):e2101923. PubMed ID: 34719887
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR-25 promotes glioblastoma cell proliferation and invasion by directly targeting NEFL.
    Peng G; Yuan X; Yuan J; Liu Q; Dai M; Shen C; Ma J; Liao Y; Jiang W
    Mol Cell Biochem; 2015 Nov; 409(1-2):103-11. PubMed ID: 26209061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.